B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers

Historically, multiple sclerosis (MS) has been viewed as being primarily driven by T cells. However, the effective use of anti-CD20 treatment now also reveals an important role for B cells in MS patients. The results from this treatment put forward T-cell activation rather than antibody production b...

Descripción completa

Detalles Bibliográficos
Autores principales: van Langelaar, Jamie, Rijvers, Liza, Smolders, Joost, van Luijn, Marvin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225320/
https://www.ncbi.nlm.nih.gov/pubmed/32457742
http://dx.doi.org/10.3389/fimmu.2020.00760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225320/
https://www.ncbi.nlm.nih.gov/pubmed/32457742
http://dx.doi.org/10.3389/fimmu.2020.00760

Ejemplares similares